1. Home
  2. ACET vs APYX Comparison

ACET vs APYX Comparison

Compare ACET & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • APYX
  • Stock Information
  • Founded
  • ACET 1947
  • APYX 1982
  • Country
  • ACET United States
  • APYX United States
  • Employees
  • ACET N/A
  • APYX N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • ACET Health Care
  • APYX Health Care
  • Exchange
  • ACET Nasdaq
  • APYX Nasdaq
  • Market Cap
  • ACET 70.3M
  • APYX 61.7M
  • IPO Year
  • ACET N/A
  • APYX 1987
  • Fundamental
  • Price
  • ACET $0.67
  • APYX $1.16
  • Analyst Decision
  • ACET Buy
  • APYX Hold
  • Analyst Count
  • ACET 6
  • APYX 2
  • Target Price
  • ACET $6.00
  • APYX N/A
  • AVG Volume (30 Days)
  • ACET 312.0K
  • APYX 52.6K
  • Earning Date
  • ACET 03-06-2025
  • APYX 05-08-2025
  • Dividend Yield
  • ACET N/A
  • APYX N/A
  • EPS Growth
  • ACET N/A
  • APYX N/A
  • EPS
  • ACET N/A
  • APYX N/A
  • Revenue
  • ACET N/A
  • APYX $48,102,000.00
  • Revenue This Year
  • ACET N/A
  • APYX $1.85
  • Revenue Next Year
  • ACET N/A
  • APYX $7.72
  • P/E Ratio
  • ACET N/A
  • APYX N/A
  • Revenue Growth
  • ACET N/A
  • APYX N/A
  • 52 Week Low
  • ACET $0.67
  • APYX $0.93
  • 52 Week High
  • ACET $2.40
  • APYX $1.99
  • Technical
  • Relative Strength Index (RSI)
  • ACET 32.94
  • APYX 43.35
  • Support Level
  • ACET $0.74
  • APYX $0.93
  • Resistance Level
  • ACET $0.91
  • APYX $1.43
  • Average True Range (ATR)
  • ACET 0.06
  • APYX 0.13
  • MACD
  • ACET -0.01
  • APYX 0.01
  • Stochastic Oscillator
  • ACET 0.36
  • APYX 35.89

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: